Benjamin Hess
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Benjamin Hess has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Annika Reintam Blaser
Department of Anaesthesiology and Intensive Care University of Tartu Tartu Estonia
5 shared publications - Joel Starkopf
Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
5 shared publications - Merli Koitmäe
Institute of Mathematics and Statistics, University of Tartu, Tartu, Estonia
5 shared publications - Cecilia Inés Loudet
Hospital General San Martin de La Plata, Buenos Aires, Argentina
4 shared publications - Dumitru Casian
Nicolae Testemițanu State University of Medicine and Pharmacy, Chisinau, Moldova, Republic of
4 shared publications - Hanne Fuglseth
Stavanger University Hospital, Stavanger, Norway
4 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Springer Nature in Critical Care
Validation of the GastroIntestinal Dysfunction Score (GIDS): prospective observational multicentre study (GUTPHOS Study)
- 30 September 2026
- Published by Springer Nature in Critical Care
Open AccessValidation of the GastroIntestinal Dysfunction Score (GIDS): prospective observational multicentre study (GUTPHOS Study)
- Open Access
- 28 August 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-12
CT-based radiological score (AMESI CT-score) for severity of bowel injury in acute mesenteric ischemia
- 28 August 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-12
Open AccessCT-based radiological score (AMESI CT-score) for severity of bowel injury in acute mesenteric ischemia
- Open Access
- 17 March 2026
- Published by Elsevier in SSRN Electronic Journal
Clinical Characteristics and Outcomes of Non-occlusive Mesenteric Ischemia: A Substudy of a Prospective Multicenter Observational Cohort
BackgroundNon-occlusive mesenteric ischemia (NOMI) remains poorly described and defined in the literature. This study aims to describe the clinical profile, risk factors, diagnostics, management, and outcomes of NOMI patients within the prospective multicenter AMESI cohort.MethodsPatients with NOMI were compared to patients with other subtypes of AMI, and patients with suspected but not confirmed AMI.ResultsNOMI patients (n=55) had a median age of 70, and 61.8% were male. At diagnosis, NOMI patients were more critically ill than other AMI (231 arterial, 73 venous, 48 with an unclear mechanism) or no AMI (n=159) patients, with median SOFA and APACHE II scores of 11 and 25, respectively. Shock at the time of suspicion (54.5%) was the most common initial sign. Although median lactate levels were elevated (4.3 mmol/L), 25.4% had normal lactate at diagnosis. Despite being used as a first-line diagnostic tool in 83.6% of NOMI cases, CT confirmed the diagnosis in only 52.7%. In-hospital mortality was 72.7%, the highest among subtypes of AMI. History of myocardial infarction, vasopressor use, and raised creatinine at the time of suspicion predicted NOMI. Bowel necrosis predicted mortality and ongoing antiplatelet therapy was associated with survival. AMI Patients with an unclear mechanism resembled NOMI in comorbidity burden and mortality, despite having a less severe illness.ConclusionsCompared with other AMI subtypes, NOMI patients were more critically ill. CT confirmed the diagnosis in only half of the cases. Difficulties in diagnosis likely contributed to missed cases and persistently poor outcomes observed in NOMI patients.
- 17 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessClinical Characteristics and Outcomes of Non-occlusive Mesenteric Ischemia: A Substudy of a Prospective Multicenter Observational Cohort
BackgroundNon-occlusive mesenteric ischemia (NOMI) remains poorly described and defined in the literature. This study aims to describe the clinical profile, risk factors, diagnostics, management, and outcomes of NOMI patients within the prospective multicenter AMESI cohort.MethodsPatients with NOMI were compared to patients with other subtypes of AMI, and patients with suspected but not confirmed AMI.ResultsNOMI patients (n=55) had a median age of 70, and 61.8% were male. At diagnosis, NOMI patients were more critically ill than other AMI (231 arterial, 73 venous, 48 with an unclear mechanism) or no AMI (n=159) patients, with median SOFA and APACHE II scores of 11 and 25, respectively. Shock at the time of suspicion (54.5%) was the most common initial sign. Although median lactate levels were elevated (4.3 mmol/L), 25.4% had normal lactate at diagnosis. Despite being used as a first-line diagnostic tool in 83.6% of NOMI cases, CT confirmed the diagnosis in only 52.7%. In-hospital mortality was 72.7%, the highest among subtypes of AMI. History of myocardial infarction, vasopressor use, and raised creatinine at the time of suspicion predicted NOMI. Bowel necrosis predicted mortality and ongoing antiplatelet therapy was associated with survival. AMI Patients with an unclear mechanism resembled NOMI in comorbidity burden and mortality, despite having a less severe illness.ConclusionsCompared with other AMI subtypes, NOMI patients were more critically ill. CT confirmed the diagnosis in only half of the cases. Difficulties in diagnosis likely contributed to missed cases and persistently poor outcomes observed in NOMI patients.
- Open Access
- 30 November 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (23) , 2705
Diagnostic Performance of Clinical and Routine Laboratory Data in Acute Mesenteric Arterial Occlusion—An International Multicenter Study
Background: There are no clinical or laboratory markers that can diagnose acute mesenteric ischemia (AMI) accurately. This study aimed to find differences in clinical and laboratory markers between arterial occlusive AMI and other acute abdominal diseases where AMI was initially suspected. Methods: This was a post hoc study of an international prospective multicenter study where data on patients with suspected AMI were collected. Independent factors associated with arterial occlusive AMI were evaluated in a multivariable logistic regression analysis. Results: The number of patients with arterial occlusive AMI was 231, consisting of thrombotic (n = 104), embolic (n = 61), and indeterminate (n = 66) occlusions. The non-AMI group included 287 patients, of whom 128 had strangulated bowel obstruction. Current smoking (odds ratio [OR] 2.56, 95% confidence interval [CI] 1.31–5.03), hypertension (OR 2.08, 95% CI 1.09–3.97), bowel emptying (OR 3.25, 95% CI 1.59–6.63), and leukocytosis (OR 1.54, 95% CI 1.14–2.08) at admission were independently associated with arterial occlusive AMI compared to the non-AMI group. Conclusions: This study found clinical and laboratory data to be associated with arterial occlusive AMI in patients with suspicion of AMI, which can possibly be of value in screening for arterial occlusive AMI at the emergency department. Further studies are needed to find more accurate diagnostic markers.
- 30 November 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (23) , 2705
Open AccessDiagnostic Performance of Clinical and Routine Laboratory Data in Acute Mesenteric Arterial Occlusion—An International Multicenter Study
Background: There are no clinical or laboratory markers that can diagnose acute mesenteric ischemia (AMI) accurately. This study aimed to find differences in clinical and laboratory markers between arterial occlusive AMI and other acute abdominal diseases where AMI was initially suspected. Methods: This was a post hoc study of an international prospective multicenter study where data on patients with suspected AMI were collected. Independent factors associated with arterial occlusive AMI were evaluated in a multivariable logistic regression analysis. Results: The number of patients with arterial occlusive AMI was 231, consisting of thrombotic (n = 104), embolic (n = 61), and indeterminate (n = 66) occlusions. The non-AMI group included 287 patients, of whom 128 had strangulated bowel obstruction. Current smoking (odds ratio [OR] 2.56, 95% confidence interval [CI] 1.31–5.03), hypertension (OR 2.08, 95% CI 1.09–3.97), bowel emptying (OR 3.25, 95% CI 1.59–6.63), and leukocytosis (OR 1.54, 95% CI 1.14–2.08) at admission were independently associated with arterial occlusive AMI compared to the non-AMI group. Conclusions: This study found clinical and laboratory data to be associated with arterial occlusive AMI in patients with suspicion of AMI, which can possibly be of value in screening for arterial occlusive AMI at the emergency department. Further studies are needed to find more accurate diagnostic markers.
- Top Cited PapersOpen Access
- 23 January 2024
- Published by Springer Nature in Critical Care
- Vol. 28 (1) , 1-17
Incidence, diagnosis, management and outcome of acute mesenteric ischaemia: a prospective, multicentre observational study (AMESI Study)
Background: The aim of this multicentre prospective observational study was to identify the incidence, patient characteristics, diagnostic pathway, management and outcome of acute mesenteric ischaemia (AMI). Methods: All adult patients with clinical suspicion of AMI admitted or transferred to 32 participating hospitals from 06.06.2022 to 05.04.2023 were included. Participants who were subsequently shown not to have AMI or had localized intestinal gangrene due to strangulating bowel obstruction had only baseline and outcome data collected. Results: AMI occurred in 0.038% of adult admissions in participating acute care hospitals worldwide. From a total of 705 included patients, 418 patients had confirmed AMI. In 69% AMI was the primary reason for admission, while in 31% AMI occurred after having been admitted with another diagnosis. Median time from onset of symptoms to hospital admission in patients admitted due to AMI was 24 h (interquartile range 9-48h) and time from admission to diagnosis was 6h (1–12 h). Occlusive arterial AMI was diagnosed in 231 (55.3%), venous in 73 (17.5%), non-occlusive (NOMI) in 55 (13.2%), other type in 11 (2.6%) and the subtype could not be classified in 48 (11.5%) patients. Surgery was the initial management in 242 (58%) patients, of which 59 (24.4%) underwent revascularization. Endovascular revascularization alone was carried out in 54 (13%), conservative treatment in 76 (18%) and palliative care in 46 (11%) patients. From patients with occlusive arterial AMI, revascularization was undertaken in 104 (45%), with 40 (38%) of them in one site admitting selected patients. Overall in-hospital and 90-day mortality of AMI was 49% and 53.3%, respectively, and among subtypes was lowest for venous AMI (13.7% and 16.4%) and highest for NOMI (72.7% and 74.5%). There was a high variability between participating sites for most variables studied. Conclusions: The overall incidence of AMI and AMI subtypes varies worldwide, and case ascertainment is challenging. Pre-hospital delay in presentation was greater than delays after arriving at hospital. Surgery without revascularization was the most common management approach. Nearly half of the patients with AMI died during their index hospitalization. Together, these findings suggest a need for greater awareness of AMI, and better guidance in diagnosis and management. Trial registration: NCT05218863 (registered 19.01.2022).
- 23 January 2024
- Published by Springer Nature in Critical Care
- Vol. 28 (1) , 1-17
Top Cited PapersOpen AccessIncidence, diagnosis, management and outcome of acute mesenteric ischaemia: a prospective, multicentre observational study (AMESI Study)
Background: The aim of this multicentre prospective observational study was to identify the incidence, patient characteristics, diagnostic pathway, management and outcome of acute mesenteric ischaemia (AMI). Methods: All adult patients with clinical suspicion of AMI admitted or transferred to 32 participating hospitals from 06.06.2022 to 05.04.2023 were included. Participants who were subsequently shown not to have AMI or had localized intestinal gangrene due to strangulating bowel obstruction had only baseline and outcome data collected. Results: AMI occurred in 0.038% of adult admissions in participating acute care hospitals worldwide. From a total of 705 included patients, 418 patients had confirmed AMI. In 69% AMI was the primary reason for admission, while in 31% AMI occurred after having been admitted with another diagnosis. Median time from onset of symptoms to hospital admission in patients admitted due to AMI was 24 h (interquartile range 9-48h) and time from admission to diagnosis was 6h (1–12 h). Occlusive arterial AMI was diagnosed in 231 (55.3%), venous in 73 (17.5%), non-occlusive (NOMI) in 55 (13.2%), other type in 11 (2.6%) and the subtype could not be classified in 48 (11.5%) patients. Surgery was the initial management in 242 (58%) patients, of which 59 (24.4%) underwent revascularization. Endovascular revascularization alone was carried out in 54 (13%), conservative treatment in 76 (18%) and palliative care in 46 (11%) patients. From patients with occlusive arterial AMI, revascularization was undertaken in 104 (45%), with 40 (38%) of them in one site admitting selected patients. Overall in-hospital and 90-day mortality of AMI was 49% and 53.3%, respectively, and among subtypes was lowest for venous AMI (13.7% and 16.4%) and highest for NOMI (72.7% and 74.5%). There was a high variability between participating sites for most variables studied. Conclusions: The overall incidence of AMI and AMI subtypes varies worldwide, and case ascertainment is challenging. Pre-hospital delay in presentation was greater than delays after arriving at hospital. Surgery without revascularization was the most common management approach. Nearly half of the patients with AMI died during their index hospitalization. Together, these findings suggest a need for greater awareness of AMI, and better guidance in diagnosis and management. Trial registration: NCT05218863 (registered 19.01.2022).
- Open Access
- 5 January 2023
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 54, 194-205
Management of acute mesenteric ischaemia: Results of a worldwide survey
- 5 January 2023
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 54, 194-205
Open AccessManagement of acute mesenteric ischaemia: Results of a worldwide survey
- 9 June 2020
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (9) , 1683-1695
Hypertonic saline for fluid resuscitation in ICU patients post-cardiac surgery (HERACLES): a double-blind randomized controlled clinical trial
Purpose Recent evidence questions a liberal approach to fluid resuscitation in intensive care unit (ICU) patients. Here, we assess whether use of hypertonic saline applied as single infusion at ICU admission after cardiac surgery can reduce cumulative perioperative fluid volume. Methods Prospective randomized double-blind single-center clinical trial investigates effects of a single infusion of hypertonic saline (HS) versus normal saline (comparator). Primary endpoint was the cumulative amount of fluid administered in patients in the hypertonic saline versus the 0.9% saline groups (during ICU stay). Upon ICU admission, patients received a single infusion of 5 ml/kg body weight of 7.3% NaCl (or 0.9% NaCl) over 60 min. Patients undergoing cardiac surgery for elective valvular and/or coronary heart disease were included. Patients with advanced organ dysfunction, infection, and/or patients on chronic steroid medication were excluded. Results A total of 101 patients were randomized to receive the study intervention (HS n = 53, NS n = 48). Cumulative fluid intake on the ICU (primary endpoint) did not differ between the HS and the NS groups [median 3193 ml (IQR 2052–4333 ml) vs. 3345 ml (IQR 2332–5043 ml)]. Postoperative urinary output until ICU discharge was increased in HS-treated patients [median 2250 ml (IQR 1640–2690 ml) vs. 1545 ml (IQR 1087–1976 ml)], and ICU fluid balance was lower in the HS group when compared to the NS group [296 ml (IQR − 441 to 1412 ml) vs. 1137 ml (IQR 322–2660 ml)]. Conclusion In a monocentric prospective double-blind randomized clinical trial, we observed that hypertonic saline did not reduce the total fluid volume administered on the ICU in critically ill cardiac surgery patients. Hypertonic saline infusion was associated with timely increase in urinary output. Variations in electrolyte and acid–base homeostasis were transient, but substantial in all patients.
- 9 June 2020
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (9) , 1683-1695
Hypertonic saline for fluid resuscitation in ICU patients post-cardiac surgery (HERACLES): a double-blind randomized controlled clinical trial
Purpose Recent evidence questions a liberal approach to fluid resuscitation in intensive care unit (ICU) patients. Here, we assess whether use of hypertonic saline applied as single infusion at ICU admission after cardiac surgery can reduce cumulative perioperative fluid volume. Methods Prospective randomized double-blind single-center clinical trial investigates effects of a single infusion of hypertonic saline (HS) versus normal saline (comparator). Primary endpoint was the cumulative amount of fluid administered in patients in the hypertonic saline versus the 0.9% saline groups (during ICU stay). Upon ICU admission, patients received a single infusion of 5 ml/kg body weight of 7.3% NaCl (or 0.9% NaCl) over 60 min. Patients undergoing cardiac surgery for elective valvular and/or coronary heart disease were included. Patients with advanced organ dysfunction, infection, and/or patients on chronic steroid medication were excluded. Results A total of 101 patients were randomized to receive the study intervention (HS n = 53, NS n = 48). Cumulative fluid intake on the ICU (primary endpoint) did not differ between the HS and the NS groups [median 3193 ml (IQR 2052–4333 ml) vs. 3345 ml (IQR 2332–5043 ml)]. Postoperative urinary output until ICU discharge was increased in HS-treated patients [median 2250 ml (IQR 1640–2690 ml) vs. 1545 ml (IQR 1087–1976 ml)], and ICU fluid balance was lower in the HS group when compared to the NS group [296 ml (IQR − 441 to 1412 ml) vs. 1137 ml (IQR 322–2660 ml)]. Conclusion In a monocentric prospective double-blind randomized clinical trial, we observed that hypertonic saline did not reduce the total fluid volume administered on the ICU in critically ill cardiac surgery patients. Hypertonic saline infusion was associated with timely increase in urinary output. Variations in electrolyte and acid–base homeostasis were transient, but substantial in all patients.